Skip to main content
OpenTrials

Clinical trial condition

Secondary Progressive Multiple Sclerosis

Explore clinical trials studying Secondary Progressive Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

42 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Secondary Progressive Multiple Sclerosis trial results

Completed

Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis

NCT01684761

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Atrophy, +12 more
Locations
  • HOPE Research Institute Phoenix, Arizona, United States
  • Northwest NeuroSpecialists, LLC Tucson, Arizona, United States
  • Alta Bates Summit Medical Center, The Research and Education Development Institute Berkeley, California, United States
  • Neurology Associates, P.A. Maitland, Florida, United States
View all 36 locations
View Trial Details
Completed

Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)

NCT00559702

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Berkeley, California, United States
  • Research Site Centennial, Colorado, United States
View Trial Details
Completed

A Study for Patients With Secondary Progressive Multiple Sclerosis

NCT00869726

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • St. Michaels Hospital Toronto, Ontario, Canada
  • Copenhagen University Hospital Copenhagen, Denmark
  • West Tallinn Central Hospital Tallinn, Estonia
  • Terveystalo Turku Kuvantaminen Turku, Finland
View Trial Details
Active, Not Recruiting

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

NCT06292923

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Yale North Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

NCT04688788

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • Danish Multiple Sclerosis Center, Rigshospitalet Glostrup Municipality, Copenhagen, Denmark
  • Department of Neurology, Aalborg University Hospital Aalborg, Denmark
  • Department of Neurology, Aarhus University Hospital Aarhus, Denmark
  • Department of Neurology, Hospital of South West Jutland, Esbjerg Esbjerg, Denmark
View Trial Details

Related conditions